Corrin Drakulich is a Principal and Litigation Group Leader in the Atlanta office. She specializes in intellectual property litigation with an emphasis on patent litigation. Ms. Drakulich has successfully represented plaintiffs and defendants in patent cases spanning a wide range of technologies, including medical devices, biotechnology, pharmaceuticals, healthcare technology, automotive technology, manufacturing technology, and consumer products. Ms. Drakulich has also successfully represented clients in trademark and product liability litigations. She has substantial experience in all major aspects of litigation from pre-suit diligence through trial and post-trial, and also counsels clients regularly on due diligence considerations and freedom to operate studies. In 2017, Ms. Drakulich was recognized by the Daily Report as one of 30 young lawyers “On the Rise” and was a recipient of the “Women Worth Watching” award by Profiles in Diversity Journal. She has also been named a Rising Star in Intellectual Property Litigation by Super Lawyers multiple times.
In addition to her intellectual property practice, Ms. Drakulich volunteers with the Atlanta Volunteer Lawyers Foundation (AVLF), representing survivors of domestic violence in hearings to obtain protective orders to shield their families from future violence. Ms. Drakulich has also co-taught a course on Patent Litigation at the Emory School of Law and served as a supervising attorney for the IP Lab practicum at the UC Berkeley School of Law.
Ms. Drakulich earned her Juris Doctor degree from the University of California at Berkeley (Boalt Hall), where she served as the Editor-in-Chief of the Berkeley Technology Law Journal, earned a Certificate of Specialization in Law & Technology, and was awarded the Boalt Moot Court Advocacy Award. Ms. Drakulich also served as a Judicial Extern for the Honorable Ronald D. Thom of the Fifth Judicial District of Oregon.
Ms. Drakulich graduated first in her class from the University of Georgia, receiving a Bachelor of Science degree in Microbiology and a Bachelor of Arts degree in Comparative Religion. She was awarded Academic All-American honors as a pole-vaulter on the University of Georgia track and field team and, upon graduating, was the 2004 recipient of the NCAA Walter Byers Postgraduate Scholarship (awarded to the top collegiate scholar-athlete in the country). Prior to attending law school, Ms. Drakulich held research positions at the Adang Laboratory and ViaGen, Inc. Swine and Cattle Cloning Company in Athens, Georgia.
2017 “Women Worth Watching” Award, Profiles in Diversity Journal
“Rising Star” Award, Super Lawyers Magazine
Selected publications and presentations
“The Most Important Cases of 2017 & Perspectives on 2018,” Consero IP Forum for Life Sciences (Newport Beach, CA, December 5, 2017)
“Advanced Strategies for Life Sciences Companies: IPR and FDA Regulatory Strategy,” Georgia Bio Innovation Summit (Atlanta, GA, November 2, 2015)
“Making Sense of Inter Partes Review Proceedings,” Cantor Fitzgerald’s Inaugural Healthcare Conference, Keynote Speaker (New York, July 8, 2015).
“Hot Topics in Intellectual Property,” Daily Report’s In-House Counsel CLE Seminar (Atlanta, GA, July 25, 2013).
“Change Leadership: Do You Want To Make a Difference?” ChIPs event with panelists Corrin Drakulich, Katherine Kelly Lutton, Noreen Krall and Anirma Gupta (Menlo Park, CA, October 28, 2010).
“University of Rochester v. G.D. Searle & Co.: In Search of a Written Description Standard,” Berkeley Tech. L.J., 21, 11 (2006), cited in Chisum on Patents.
Medigus Ltd. v. EndoChoice, Inc.(D. Del.) – Defended EndoChoice against Medigus’ assertion of a patent related to endoscopes. Case resulted in settlement favorable to client on eve of claim construction hearing.
EndoChoice, Inc. v. Medigus Ltd. and Medigus USA LLC(D. Del.) – Represented EndoChoice in enforcement of trademark rights related to endoscopy products. Case resulted in settlement favorable to client.
In re Fresenius GranuFlo/NaturaLyte Dialysate Products Liability Litigation (MDL and various state court actions). Defended Fresenius in products liability mass tort litigation relating to the use of acid concentrate products during dialysis, which the plaintiffs alleged resulted in sudden cardiac arrest. Obtained favorable global settlement following defense verdict of no causation at the first and only bellwether trial.
Ogburn-Sisneros v. Fresenius Medical Care Holdings, Inc. (Mass. Sup. Ct.). Defended Fresenius in three-week trial in which plaintiff alleged use of GranuFlo granulated acid concentrate in hemodialysis treatment caused patient’s death. Obtained defense verdict of no causation.
Baxter International, Inc. v. Fresenius Medical Care (N.D. Ill.) – Defended Fresenius against Baxter’s assertion of patents related to peritoneal dialysis systems. Case resulted in settlement favorable to client.
St. Jude Medical v. Volcano Corp. (D. Del.) –Defended Volcano against St. Jude’s assertion of a patent related to cardiac guidewire consoles. Case resulted in settlement favorable to client.
Allergan Sales, LLC v. Lupin Ltd. et al. and Consolidated Cases against Alcon, Apotex & Akorn (E.D. Tex.) – Represented Allergan in assertion of pharmaceutical patents related to ophthalmic non-steroidal anti-inflammatory drugs against generic manufacturers. All cases resulted in settlements favorable to client.
St. Jude Medical v. Volcano Corp. (D. Del.) – Defended Volcano in patent litigation and jury trial related to pressure sensing guide wires used to diagnose heart problems. At trial, jury found two St. Jude patents invalid, two not infringed; a fifth patent was declared not infringed by the court on the eve of trial.
BorgWarner, Inc. v. Honeywell Int’l, Inc. (W.D.N.C.) – Represented BorgWarner in assertion of patents relating to the design and manufacture of turbocharger components. Case resulted in settlement for $32.5 million to client.
Baxter Healthcare Corp. v. Fresenius Medical Care (N.D. Cal.) – Defended Fresenius against Baxter’s assertion of patents related to peritoneal dialysis systems. At trial, jury found Fresenius did not infringe Baxter’s patents.
Allergan, Inc., et al. v. Watson Laboratories, Inc. – Florida, et al. (D. Del.) – Represented Allergan, Endo Pharmaceuticals and Supernus Pharmaceuticals in assertion of pharmacological patents for treatment of overactive bladder against generic manufacturers.
Corbett Life Sciences v. Applied Biosystems, Inc. (N.D. Cal.) – Represented Applied Biosystems in assertion of realtime PCR instrument patent. Case resulted in settlement favorable to client.
Fluidigm Corporation v. Applied Biosystems, Inc. (S.D. N.Y.) – Represented Applied Biosystems in assertion of realtime PCR instrument patent. Case resulted in settlement favorable to client.